SB 140 CO

0likes☆Favorite🔕SubscribeShare

Passed One Chamber

The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; orA licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

• L. Frizell Republican · sponsor
• J. Marchman Democratic · sponsor
• L. Gilchrist Democratic · sponsor
• D. Johnson Republican · sponsor
• J. Amabile Democratic · sponsor
• S. Bright Republican · sponsor
• J. Carson Republican · sponsor
• I. Jodeh Democratic · sponsor
• B. Kirkmeyer Republican · sponsor
• C. Simpson Republican · sponsor
• M. Bradfield Republican · sponsor
• A. Hartsook Republican · sponsor
• J. Joseph Democratic · sponsor
• R. Taggart Republican · sponsor

1. Apr 22, 2026 House Committee on Health & Human Services Postpone Indefinitely · lower
2. Apr 21, 2026 Introduced In House - Assigned to Health & Human Services · lower
3. Apr 13, 2026 Senate Third Reading Passed - No Amendments · upper
4. Apr 10, 2026 Senate Third Reading Laid Over to 04/13/2026 - No Amendments · upper
5. Apr 9, 2026 Senate Second Reading Passed - No Amendments · upper
6. Apr 8, 2026 Senate Second Reading Laid Over to 04/09/2026 - No Amendments · upper
7. Apr 2, 2026 Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole · upper
8. Mar 16, 2026 Introduced In Senate - Assigned to Health & Human Services · upper